{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T12:46:12Z","timestamp":1767530772629},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,8]]},"DOI":"10.7759\/cureus.17002","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T17:21:56Z","timestamp":1628443316000},"source":"Crossref","is-referenced-by-count":7,"title":["Unraveling the Association Between Myocardial Infarction of Nonobstructive Coronary Arteries and Anti-phospholipid Syndrome"],"prefix":"10.7759","author":[{"given":"Vishal","family":"Ramjas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpit","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rholter Dave M","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fioni","family":"Fioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouran","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pousette","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.09.097","article-title":"Memorable cardiology quotes","volume":"103","author":"Franklin BA","year":"2009","unstructured":"Franklin BA. Memorable cardiology quotes. Am J Cardiol. 2009, 103:428-30. 10.1016\/j.amjcard.2008.09.097","journal-title":"Am J Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the american heart association","volume":"139","author":"Tamis-Holland JE","year":"2019","unstructured":"Tamis-Holland JE, Jneid H, Reynolds HR, et al.. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the american heart association. Circulation. 2019, 139:e891-908. 10.1161\/CIR.0000000000000670","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2015.10.2.79","article-title":"Myocardial infarction with non-obstructive coronary arteries - diagnosis and management","volume":"10","author":"Pasupathy S","year":"2015","unstructured":"Pasupathy S, Tavella R, McRae S, Beltrame JF. Myocardial infarction with non-obstructive coronary arteries - diagnosis and management. Eur Cardiol. 2015, 10:79-82. 10.15420\/ecr.2015.10.2.79","journal-title":"Eur Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(99)00126-6","article-title":"ACC\/AHA guidelines for coronary angiography. A report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the society for cardiac angiography and interventions","volume":"33","author":"Scanlon PJ","year":"1999","unstructured":"Scanlon PJ, Faxon DP, Audet AM, et al.. ACC\/AHA guidelines for coronary angiography. A report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the society for cardiac angiography and interventions. J Am Coll Cardiol. 1999, 33:1756-824. 10.1016\/s0735-1097(99)00126-6","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2018.12.015","article-title":"Prevalence of myocardial infarction with non-obstructive coronary arteries (MINOCA) amongst acute coronary syndrome in patients with antiphospholipid syndrome","volume":"22","author":"Gandhi H","year":"2019","unstructured":"Gandhi H, Ahmed N, Spevack DM. Prevalence of myocardial infarction with non-obstructive coronary arteries (MINOCA) amongst acute coronary syndrome in patients with antiphospholipid syndrome. Int J Cardiol Heart Vasc. 2019, 22:148-9. 10.1016\/j.ijcha.2018.12.015","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/621270","article-title":"Cardiovascular risk factors in the antiphospholipid syndrome","volume":"2014","author":"da Silva FF","year":"2014","unstructured":"da Silva FF, Levy RA, de Carvalho JF. Cardiovascular risk factors in the antiphospholipid syndrome. J Immunol Res. 2014, 2014:621270. 10.1155\/2014\/621270","journal-title":"J Immunol Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5727","article-title":"In-situ coronary thrombosis in antiphospholipid syndrome: a case report","volume":"11","author":"Pervez H","year":"2019","unstructured":"Pervez H, Rufus S, Gopalakrishnan P. In-situ coronary thrombosis in antiphospholipid syndrome: a case report. Cureus. 2019, 11:e5727. 10.7759\/cureus.5727","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-011-8268-9","article-title":"Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome","volume":"44","author":"Gualtierotti R","year":"2013","unstructured":"Gualtierotti R, Biggioggero M, Meroni PL. Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome. Clin Rev Allergy Immunol. 2013, 44:51-6. 10.1007\/s12016-011-8268-9","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3329\/uhj.v12i1.34027","article-title":"Primary antiphospholipid syndrome presenting with acute ST elevated MI with normal coronaries","volume":"12","author":"Islam","year":"2017","unstructured":"Islam, Lohani, A. Chowdhury, et al.. Primary antiphospholipid syndrome presenting with acute ST elevated MI with normal coronaries. University Heart Journal. 2017, 12:49-50. 10.3329\/uhj.v12i1.34027","journal-title":"University Heart Journal"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.6515\/ACS.201911_35(6).20190829A","article-title":"Acute myocardial infarction involving left main artery in a patient with antiphospholipid syndrome","volume":"35","author":"Wang WH","year":"2019","unstructured":"Wang WH, Chen YC, Hsieh MH. Acute myocardial infarction involving left main artery in a patient with antiphospholipid syndrome. Acta Cardiol Sin. 2019, 35:655-8. 10.6515\/ACS.201911_35(6).20190829A","journal-title":"Acta Cardiol Sin"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14740\/cr661w","article-title":"Coronary artery thromboses, stent thrombosis and antiphospholipid antibody syndrome: case report","volume":"9","author":"Correia AF","year":"2018","unstructured":"Correia AF, Oliveira DC, Sanctos M. Coronary artery thromboses, stent thrombosis and antiphospholipid antibody syndrome: case report. Cardiol Res. 2018, 9:129-32. 10.14740\/cr661w","journal-title":"Cardiol Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003200","article-title":"Impact of antiphospholipid syndrome and\/or systemic lupus erythematosus on the long-term adverse cardiovascular outcomes in patients after percutaneous coronary intervention: a systematic review and meta-analysis","volume":"95","author":"Bundhun PK","year":"2016","unstructured":"Bundhun PK, Boodhoo KD, Long MY, Chen MH. Impact of antiphospholipid syndrome and\/or systemic lupus erythematosus on the long-term adverse cardiovascular outcomes in patients after percutaneous coronary intervention: a systematic review and meta-analysis. Medicine (Baltimore). 2016, 95:e3200. 10.1097\/MD.0000000000003200","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/63753","article-title":"Myocardial ischaemia, coronary atherosclerosis and pulmonary pressure elevation in antiphospholipid syndrome patients","volume":"25","author":"Padjas A","year":"2016","unstructured":"Padjas A, P\u0142azak W, Celi\u0144ska-Lowenhoff M, Mazurek A, Perricone C, Podolec P, Musia\u0142 J. Myocardial ischaemia, coronary atherosclerosis and pulmonary pressure elevation in antiphospholipid syndrome patients. Adv Clin Exp Med. 2016, 25:1199-205. 10.17219\/acem\/63753","journal-title":"Adv Clin Exp Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1191\/0961203304lu1011oa","article-title":"Antiphospholipid antibodies in acute coronary syndrome","volume":"13","author":"Veres K","year":"2004","unstructured":"Veres K, Lakos G, Ker\u00e9nyi A, Szekanecz Z, Szegedi G, Shoenfeld Y, Solt\u00e9sz P. Antiphospholipid antibodies in acute coronary syndrome. Lupus. 2004, 13:423-7. 10.1191\/0961203304lu1011oa","journal-title":"Lupus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8071084","article-title":"Silent myocardial perfusion abnormalities detected by stress cardiovascular magnetic resonance in antiphospholipid syndrome: a case-control study","volume":"8","author":"Mavrogeni SI","year":"2019","unstructured":"Mavrogeni SI, Markousis-Mavrogenis G, Karapanagiotou O, et al.. Silent myocardial perfusion abnormalities detected by stress cardiovascular magnetic resonance in antiphospholipid syndrome: a case-control study. J Clin Med. 2019, 8:10.3390\/jcm8071084","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.15415","article-title":"Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat?","volume":"131","author":"Calcaterra I","year":"2021","unstructured":"Calcaterra I, Tufano A, Lupoli R, Iannuzzo G, Emmi G, Di Minno MN. Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat?. Pol Arch Intern Med. 2021, 131:161-70. 10.20452\/pamw.15415","journal-title":"Pol Arch Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-12-974","article-title":"Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome","volume":"116","author":"Kattwinkel N","year":"1992","unstructured":"Kattwinkel N, Villanueva AG, Labib SB, Aretz HT, Walek JW, Burns DL, Klenz JT. Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome. Ann Intern Med. 1992, 116:974-6. 10.7326\/0003-4819-116-12-974","journal-title":"Ann Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.02.058","article-title":"Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics","volume":"69","author":"Corban MT","year":"2017","unstructured":"Corban MT, Duarte-Garcia A, McBane RD, Matteson EL, Lerman LO, Lerman A. Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics. J Am Coll Cardiol. 2017, 69:2317-30. 10.1016\/j.jacc.2017.02.058","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/suaa057","article-title":"Myocardial infarction with non-obstructive coronary arteries: what is the prognosis?","volume":"22","author":"Niccoli G","year":"2020","unstructured":"Niccoli G, Camici PG. Myocardial infarction with non-obstructive coronary arteries: what is the prognosis?. Eur Heart J Suppl. 2020, 22:E40-5. 10.1093\/eurheartj\/suaa057","journal-title":"Eur Heart J Suppl"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera R","year":"2002","unstructured":"Cervera R, Piette JC, Font J, et al.. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002, 46:1019-27. 10.1002\/art.10187","journal-title":"Arthritis Rheum"},{"key":"ref21","article-title":"Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of serbian patients with primary and secondary antiphospholipid syndrome","volume":"16","author":"Djokovic A","year":"2014","unstructured":"Djokovic A, Stojanovich L, Kontic M, Stanisavljevic N, Radovanovic S, Marisavljevic D. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of serbian patients with primary and secondary antiphospholipid syndrome. Isr Med Assoc J. 2014, 16:162-7.","journal-title":"Isr Med Assoc J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005587","article-title":"Coronary embolism among st-segment-elevation myocardial infarction patients: mechanisms and management","volume":"11","author":"Popovic B","year":"2018","unstructured":"Popovic B, Agrinier N, Bouchahda N, et al.. Coronary embolism among st-segment-elevation myocardial infarction patients: mechanisms and management. Circ Cardiovasc Interv. 2018, 11:e005587. 10.1161\/CIRCINTERVENTIONS.117.005587","journal-title":"Circ Cardiovasc Interv"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307086036","article-title":"Syndrome X (angina pectoris with normal coronary arteries) and myocardial infarction in patients with anti-phospholipid (Hughes) syndrome","volume":"17","author":"Sangle SR","year":"2008","unstructured":"Sangle SR, D'Cruz DP. Syndrome X (angina pectoris with normal coronary arteries) and myocardial infarction in patients with anti-phospholipid (Hughes) syndrome. Lupus. 2008, 17:83-5. 10.1177\/0961203307086036","journal-title":"Lupus"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0000000000000476","article-title":"Acute myocardial infarction and antiphospholipid antibody syndrome: a systematic review","volume":"28","author":"Nazir S","year":"2017","unstructured":"Nazir S, Tachamo N, Lohani S, Hingorani R, Poudel DR, Donato A. Acute myocardial infarction and antiphospholipid antibody syndrome: a systematic review. Coron Artery Dis. 2017, 28:332-5. 10.1097\/MCA.0000000000000476","journal-title":"Coron Artery Dis"},{"key":"ref25","article-title":"Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study","volume":"31","author":"Zavaleta NE","year":"2004","unstructured":"Zavaleta NE, Montes RM, Soto ME, Vanzzini NA, Amigo MC. Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study. J Rheumatol. 2004, 31:2402-7.","journal-title":"J Rheumatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081194","article-title":"Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus","volume":"36","author":"Danowski A","year":"2009","unstructured":"Danowski A, de Azevedo MNL, de Souza Papi JA, Petri M. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J Rheumatol. 2009, 36:1195-9. 10.3899\/jrheum.081194","journal-title":"J Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2006.05.001","article-title":"Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis","volume":"45","author":"Matsuura E","year":"2006","unstructured":"Matsuura E, Kobayashi K, Tabuchi M, Lopez LR. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res. 2006, 45:466-86. 10.1016\/j.plipres.2006.05.001","journal-title":"Prog Lipid Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307081847","article-title":"Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome","volume":"16","author":"de Souza AW","year":"2007","unstructured":"de Souza AW, Silva NP, de Carvalho JF, D'Almeida V, Noguti MA, Sato EI. Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome. Lupus. 2007, 16:782-7. 10.1177\/0961203307081847","journal-title":"Lupus"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.02.155","article-title":"The adjusted Global Antiphospholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction","volume":"240","author":"Radin M","year":"2017","unstructured":"Radin M, Schreiber K, Costanzo P, et al.. The adjusted Global Antiphospholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction. Int J Cardiol. 2017, 240:72-7. 10.1016\/j.ijcard.2017.02.155","journal-title":"Int J Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8090-5-101","article-title":"Antiphospholipid syndrome; its implication in cardiovascular diseases: a review","volume":"5","author":"Koniari I","year":"2010","unstructured":"Koniari I, Siminelakis SN, Baikoussis NG, Papadopoulos G, Goudevenos J, Apostolakis E. Antiphospholipid syndrome; its implication in cardiovascular diseases: a review. J Cardiothorac Surg. 2010, 5:101. 10.1186\/1749-8090-5-101","journal-title":"J Cardiothorac Surg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2020.0064","article-title":"Troponin-positive non-obstructive coronary arteries and myocardial infarction with non-obstructive coronary arteries: definition, etiologies, and role of CT and MR imaging","volume":"21","author":"Yoo SM","year":"2020","unstructured":"Yoo SM, Jang S, Kim JA, Chun EJ. Troponin-positive non-obstructive coronary arteries and myocardial infarction with non-obstructive coronary arteries: definition, etiologies, and role of CT and MR imaging. Korean J Radiol. 2020, 21:1305-16. 10.3348\/kjr.2020.0064","journal-title":"Korean J Radiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw149","article-title":"ESC working group position paper on myocardial infarction with non-obstructive coronary arteries","volume":"38","author":"Agewall S","year":"2017","unstructured":"Agewall S, Beltrame JF, Reynolds HR, et al.. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017, 38:143-53. 10.1093\/eurheartj\/ehw149","journal-title":"Eur Heart J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14632","article-title":"Pathogenesis and management of antiphospholipid syndrome","volume":"178","author":"Arachchillage DR","year":"2017","unstructured":"Arachchillage DR, Laffan M. Pathogenesis and management of antiphospholipid syndrome. Br J Haematol. 2017, 178:181-95. 10.1111\/bjh.14632","journal-title":"Br J Haematol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13523","article-title":"Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma: reply","volume":"14","author":"Lackner KJ","year":"2016","unstructured":"Lackner KJ, M\u00fcller-Calleja N. Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma: reply. J Thromb Haemost. 2016, 14:2563-4. 10.1111\/jth.13523","journal-title":"J Thromb Haemost"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13379","article-title":"IgG\/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis","volume":"14","author":"Kelchtermans H","year":"2016","unstructured":"Kelchtermans H, Pelkmans L, de Laat B, Devreese KM. IgG\/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis. J Thromb Haemost. 2016, 14:1530-48. 10.1111\/jth.13379","journal-title":"J Thromb Haemost"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21062012","article-title":"Role of microRNAs in the development of cardiovascular disease in systemic autoimmune disorders","volume":"21","author":"Lopez-Pedrera C","year":"2020","unstructured":"Lopez-Pedrera C, Barbarroja N, Pati\u00f1o-Trives AM, et al.. Role of microRNAs in the development of cardiovascular disease in systemic autoimmune disorders. Int J Mol Sci. 2020, 21:2012. 10.3390\/ijms21062012","journal-title":"Int J Mol Sci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400509","article-title":"Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression","volume":"40","author":"Cuadrado MJ","year":"1997","unstructured":"Cuadrado MJ, L\u00f3pez-Pedrera C, Khamashta MA, et al.. Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. Arthritis Rheum. 1997, 40:834-41. 10.1002\/art.1780400509","journal-title":"Arthritis Rheum"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.56.7804","article-title":"Intravascular images of coronary stenosis with multiple channels in a patient with antiphospholipid syndrome: the optical coherence tomography findings","volume":"56","author":"Ito S","year":"2017","unstructured":"Ito S, Hasuo T. Intravascular images of coronary stenosis with multiple channels in a patient with antiphospholipid syndrome: the optical coherence tomography findings. Intern Med. 2017, 56:1351-6. 10.2169\/internalmedicine.56.7804","journal-title":"Intern Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/srep31375","article-title":"'Atherothrombosis-associated microRNAs in antiphospholipid syndrome and systemic lupus erythematosus patients'","volume":"6","author":"P\u00e9rez-S\u00e1nchez C","year":"2016","unstructured":"P\u00e9rez-S\u00e1nchez C, Aguirre MA, Ruiz-Lim\u00f3n P, et al.. 'Atherothrombosis-associated microRNAs in antiphospholipid syndrome and systemic lupus erythematosus patients'. Sci Rep. 2016, 6:31375. 10.1038\/srep31375","journal-title":"Sci Rep"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/794898","article-title":"MicroRNAs in vascular biology","volume":"2012","author":"Yamakuchi M","year":"2012","unstructured":"Yamakuchi M. MicroRNAs in vascular biology. Int J Vasc Med. 2012, 2012:794898. 10.1155\/2012\/794898","journal-title":"Int J Vasc Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/art.39247","article-title":"Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome","volume":"67","author":"Yalavarthi S","year":"2015","unstructured":"Yalavarthi S, Gould TJ, Rao AN, et al.. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. Arthritis Rheumatol. 2015, 67:2990-3003. 10.1002\/art.39247","journal-title":"Arthritis Rheumatol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09801-x","article-title":"Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome","volume":"10","author":"Ali RA","year":"2019","unstructured":"Ali RA, Gandhi AA, Meng H, et al.. Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome. Nat Commun. 2019, 10:1916. 10.1038\/s41467-019-09801-x","journal-title":"Nat Commun"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/art.38785","article-title":"Role of toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome","volume":"66","author":"Benhamou Y","year":"2014","unstructured":"Benhamou Y, Bellien J, Armengol G, et al.. Role of toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome. Arthritis Rheumatol. 2014, 66:3210-20. 10.1002\/art.38785","journal-title":"Arthritis Rheumatol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s13317-011-0017-9","article-title":"Pathophysiology of the antiphospholipid antibody syndrome","volume":"2","author":"Willis R","year":"2011","unstructured":"Willis R, Pierangeli SS. Pathophysiology of the antiphospholipid antibody syndrome. Auto Immun Highlights. 2011, 2:35-52. 10.1007\/s13317-011-0017-9","journal-title":"Auto Immun Highlights"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-225495","article-title":"Catastrophic antiphospholipid syndrome causing ST-segment elevation myocardial infarction with non-obstructive coronary arteries","volume":"12","author":"Cranley J","year":"2019","unstructured":"Cranley J, Krishnan U, Tweed K, Duehmke RM. Catastrophic antiphospholipid syndrome causing ST-segment elevation myocardial infarction with non-obstructive coronary arteries. BMJ Case Rep. 2019, 12:10.1136\/bcr-2018-225495","journal-title":"BMJ Case Rep"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2018.1516182","article-title":"A microvascular myocardial infarction in a 16-year-old girl with antiphospholipid syndrome: a case report","volume":"74","author":"Riga JP","year":"2019","unstructured":"Riga JP, Leone A, Lambot F, Cappeliez O, Friart A. A microvascular myocardial infarction in a 16-year-old girl with antiphospholipid syndrome: a case report. Acta Clin Belg. 2019, 74:351-4. 10.1080\/17843286.2018.1516182","journal-title":"Acta Clin Belg"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2011.05.014","article-title":"Coronary microvasculopathy and intracardiac thrombosis in antiphospholipid syndrome","volume":"105","author":"Onea R","year":"2012","unstructured":"Onea R, Germain P, Zimmermann A. Coronary microvasculopathy and intracardiac thrombosis in antiphospholipid syndrome. Arch Cardiovasc Dis. 2012, 105:461-2. 10.1016\/j.acvd.2011.05.014","journal-title":"Arch Cardiovasc Dis"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.6545","article-title":"Myocardial infarction and normal coronary arteries: the experience of the cardiology department of Sfax, Tunisia","volume":"51","author":"Abid L","year":"2012","unstructured":"Abid L, Bahloul A, Frikha Z, et al.. Myocardial infarction and normal coronary arteries: the experience of the cardiology department of Sfax, Tunisia. Intern Med. 2012, 51:1959-67. 10.2169\/internalmedicine.51.6545","journal-title":"Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/61866-unraveling-the-association-between-myocardial-infarction-of-nonobstructive-coronary-arteries-and-anti-phospholipid-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:20Z","timestamp":1707506960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/61866-unraveling-the-association-between-myocardial-infarction-of-nonobstructive-coronary-arteries-and-anti-phospholipid-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,8]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.17002","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,8]]}}}